Orange projects FY 2026 EBITDAaL growth above 4.5% while keeping SFR closing timeline for H2 2027 (OTCMKTS:FNCTF)

DMC Global (BOOM) stock rose 16% in pre-market trading after reporting Q3 earnings that exceeded estimates, with EPS of $0.48 vs. $0.11 consensus and revenue of $172.8M vs. $161.1M. Adjusted EBITDA increased 59% YoY to $13.6M, and net debt fell to $13.7M. Management guided Q4 revenue between $154M-$164M, roughly in line with analyst expectations. The company cited strong performance in its Arcadia and NobelClad divisions, as well as a constructive broader market backdrop.

Robinhood (HOOD) reported Q3 net income of $476M, down 14% YoY, and EPS of $0.51, missing estimates. Revenue rose 12% to $1.42B. Trading volumes hit records, but net interest revenue fell 9%. Stock dropped 8% premarket. HOOD has lost over 15% YTD.

Unilever (ULVR) shares fell 3.0% to 4,744.5p after Q3 2026 results showed 5.2% sales growth, beating estimates but missing investor expectations due to volume deceleration. Turnover rose 6.7% to €13.3B. The Wellbeing division declined, and Foods saw minimal growth. UBS cut its target, while Bernstein maintained a Buy rating. The stock traded near session lows, down from 4,892.5p. The FTSE 100 was set to open lower.

BNP Paribas Exane upgraded Pentair (PNR) to Neutral from Underperform, raising its price target to $65.00. The move follows Pentair's Q3 earnings beat, with adjusted EPS of $1.18 on revenue of $976 million. The firm cites a reset in expectations and balanced risk-reward, noting a 39.3% YTD decline but recent 18% rebound. Pentair expects mid-teens sales growth in 2027 and benefits from the Taco acquisition.

GSK plc's stock fell 4.6% after its Q3 2026 earnings report, despite beating EPS and sales estimates. Vaccine revenues declined, and operating profit dropped 16%. The company expects lower core EPS growth for the year. Barclays maintained a Sell rating, and the FTSE 100's decline added to the pressure, pushing GSK shares to an intraday low of 1823p.

Deutsche Bank (DB) reported Q3 revenue growth in Private Bank (8%), Asset Management (4%), and Corporate Bank (9%), with record Corporate Bank revenue. Investment Bank revenue matched prior-year levels. The bank maintained its 2026 outlook, targeting €33B+ revenue and €21.3B expenses. It completed €1.5B in share buybacks and expects normalized provisions by 2028. CET1 capital ratio was 14.0%.